Key Benefits Allows for personalized dosing through individual dose adjustments 1 Supports patient adherence with once-daily administration 1,2 Provides options for different insulin requirements 1 Proven Efficacy and Safety BRIGHT Study Overview The Bright study demonstrated similar efficacy and safety of Toujeo (Glargine 300, n=466) compared to degludec 100 (n=463) in type 2 diabetes patients who had not previously received basal insulin
In the world of high-performance training, sweat is a badge of honor, but the specific scent of that sweat often sparks a flurry of questions
Eventually, the pancreas cannot produce enough insulin to keep up with the demand, and blood sugar levels go up
If you take warfarin, direct oral anticoagulants, aspirin, or other blood thinners, check with your prescriber about the risk of bruising and whether any lab monitoring is needed
10.2337/db20-0361 10 NewR
In India, over 100 million people are currently living with diabetes, and an additional 135 million are prediabetic